Search filters
Filters
Clear All

Phase

  • 183
  • 156
  • 2
  • 194
  • 1
  • 148
  • 17
  • 396
  • 1237
  • 588
  • 29
  • 49
  • 3
  • 1162
  • 1237
  • 6
  • 3
  • 1240

Found 1243 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

CentriMag Failure-to-Wean Post cardiopulmonary bypass

CentriMag Failure-to-Wean Post cardiopulmonary bypass

18 years - 99 years
All genders
Interventional
This study will gather real-world information on the post-market performance, and confirm safety and effectiveness of the CentriMag Circulatory Support System for patients surviving up 30 days post support or to hospital discharge, and for subjects who do not recover and are bridged to a heart transplant or long-term assist …
Learn More
Evaluating the Safety and Tolerability of XmAb 18087 in Subjects with Advanced Neuroendocrine and Gastrointestinal Stromal Tumors (DUET-1)

Evaluating the Safety and Tolerability of XmAb 18087 in Subjects with Advanced Neuroendocrine and Gastrointestinal Stromal Tumors (DUET-1)

12 years - 99 years
All genders
The primary purposes of this research study is to determine the safety and tolerability of the investigational drug, XmAb18087, and if the XmAb18087 works in treating tumors like you have and side effects from XmAb18087, to find the best dose for treating your type of tumor. XmAb18087 is an investigational …
Learn More
A Phase 2, Umbrella Study With Rolling Arms of Investigational Agents With Either Pembrolizumab in Combination With Chemotherapy or With Pembrolizumab Alone in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

A Phase 2, Umbrella Study With Rolling Arms of Investigational Agents With Either Pembrolizumab in Combination With Chemotherapy or With Pembrolizumab Alone in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

18 years - 99 years
All genders
Interventional
This is an umbrella study designed to learn more about how well different drugs work in non-small cell lung cancer. This study will test MK-4830, MK7-684, and MK-5890 with pembrolizumab and standard chemotherapy or with pembrolizumab alone in subjects with advanced NSCLC.
Learn More
A Randomized Multicenter Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation

A Randomized Multicenter Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation

18 years - 99 years
All genders
Interventional
This study compares 2 combinations of drugs to prevent graft-versus-host disease (GVHD): Tacrolimus/methotrexate and Tacrolimus/mycophenolate mofetil/cyclophosphamide. Doctors want to know which combination is better or if they give the same results. The study will help doctors decide which treatment is best for future transplant patients. The purpose of its companion …
Learn More
SURVEILLANCE HEARTCARE OUTCOMES REGISTRY (SHORE)

SURVEILLANCE HEARTCARE OUTCOMES REGISTRY (SHORE)

15 years - 99 years
All genders
Observational
The primary study objective is to assess the clinical utility of surveillance using HeartCare testing services, in association with clinical care of heart transplant recipients.
Learn More
A randomized double-blind placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP)

A randomized double-blind placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP)

18 years - 99 years
All genders
Phase 3
The present confirmatory phase 3 trial will be conducted to further investigate the efficacy and safety of molgramostim in subjects with aPAP. Investigating how molgramostim improves lung pathology, pathophysiology, and health status in subjects with aPAP in a dose- frequency dependent fashion.
Learn More
Long Acting Therapy to Improve Treatment SUccess in Daily LifE (The LATITUDE Study)

Long Acting Therapy to Improve Treatment SUccess in Daily LifE (The LATITUDE Study)

18 years - 70 years
All genders
Phase 3
This study is meant for patients who have difficulty taking their HIV meds as prescribed.  One goal of the study is to test the effectiveness of long-acting antiretroviral therapy (ART) -- a once-a-month injection that replaces daily ART pills. You will also receive compensation for participating in this study, with …
Learn More
Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Colorectal Cancer

Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Colorectal Cancer

18 years - 99 years
All genders
Phase 1
This study will evaluate the efficacy of investigational drug treatments combinations in patients with metastatic colorectal cancer.
Learn More
Study of the Safety Pharmacokinetics Pharmacodynamics and Preliminary Clinical Activity of RP-6306 in Patients with Advanced Solid Tumors (MYTHIC Study)

Study of the Safety Pharmacokinetics Pharmacodynamics and Preliminary Clinical Activity of RP-6306 in Patients with Advanced Solid Tumors (MYTHIC Study)

12 years - 99 years
All genders
Phase 1
The primary purpose of this study is to assess the safety and tolerability of an Investigational drug in patients with eligible advanced solid tumors, determine the maximum tolerated dose (MTD) and assess preliminary anti-tumor activity.
Learn More
A Randomized Prospective Evaluation of Four Injectable Neuromodulators in the Glabella Area

A Randomized Prospective Evaluation of Four Injectable Neuromodulators in the Glabella Area

30 years - 65 years
Female
Interventional
The overall study object is to quantify the dynamic strain of four commonly available neuromodulators using 3D imaging as well as other potential physical measurements differences over time.
Learn More
431 - 440 of 1243